Drug development takes more than expertise—it takes connection. Our experts work across disciplines, staying aligned at every phase to power the Accelerator™ Drug Development solution and move innovation forward.
This video series will highlight key components of Accelerator™ Drug Development—including enabling technologies and cross-functional support teams—to show how Thermo Fisher Scientific uniquely delivers an integrated, single-vendor pathway that reduces complexity and improves outcomes.
In this episode, Zubair Khan, Executive Director of Global Clinical Science and Development Strategy at Thermo Fisher Scientific, examines the expanding role of technology in drug development and clinical research. Zubair explores how digital innovation is accelerating timelines and improving process efficiency, what drug developers should keep in mind when integrating AI and other emerging tools responsibly, and which technologies within the Accelerator™ Drug Development programs are delivering the most meaningful benefits for customers.